TENAX THERAPEUTICS, INC. Accounts Payable
TENAX THERAPEUTICS, INC. (TENX) had Accounts Payable of $6.79 million as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-07-31
- 2026-06-30: Accounts Payable, Current $6.79M.
- 2026-03-31: Accounts Payable, Current $6.35M.
- 2025-12-31: Accounts Payable, Current $6.04M.
- 2025-09-30: Accounts Payable, Current $5.61M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $6.79M 10-Q · filed 2026-07-31 | |
| 2026-03-31 | $6.35M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $6.04M 10-Q · filed 2026-07-31 | |
| 2025-09-30 | $5.61M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $562.00K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $1.84M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $3.16M 10-K · filed 2026-03-10 | |
| 2024-09-30 | $1.58M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $869.66K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $1.08M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $2.07M 10-K · filed 2025-03-25 | $2.07M 10-K · filed 2024-03-28 |
| 2023-09-30 | $134.79K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $206.46K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $172.03K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $448.43K 10-K · filed 2024-03-28 | |
| 2022-09-30 | $265.41K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $919.38K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.29M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $859.64K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $776.25K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $791.95K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $997.44K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $757.86K 10-K · filed 2022-03-29 | |
| 2020-09-30 | $1.05M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $1.56M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $1.81M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $1.66M 10-K/A · filed 2021-04-16 | |
| 2019-09-30 | $225.52K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $448.82K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $596.81K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $749.81K 10-K · filed 2020-03-30 | |
| 2018-09-30 | $392.48K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $203.15K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $189.56K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $611.86K 10-K · filed 2019-04-01 | |
| 2017-09-30 | $579.39K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $434.19K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $1.40M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $727.60K 10-K · filed 2018-04-02 | |
| 2016-09-30 | $1.39M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $1.52M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $2.12M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $972.48K 10-K · filed 2017-03-16 | |
| 2015-10-31 | $521.23K 10-Q · filed 2015-12-10 | |
| 2015-07-31 | $680.69K 10-Q · filed 2015-09-09 | |
| 2015-04-30 | $1.18M 10-KT · filed 2016-03-14 | |
| 2015-01-31 | $425.23K 10-Q · filed 2015-03-17 | |
| 2014-10-31 | $1.65M 10-Q · filed 2014-12-15 | |
| 2014-07-31 | $585.91K 10-Q · filed 2014-09-15 | |
| 2014-04-30 | $411.14K 10-KT · filed 2016-03-14 | |
| 2014-01-31 | $668.67K 10-Q · filed 2014-03-17 | |
| 2013-10-31 | $920.84K 10-Q · filed 2013-12-17 | |
| 2013-07-31 | $969.57K 10-Q · filed 2013-09-17 | |
| 2013-04-30 | $977.16K 10-K · filed 2014-07-29 | |
| 2013-01-31 | $807.68K 10-Q · filed 2013-03-18 | |
| 2012-10-31 | $479.30K 10-Q · filed 2012-12-14 | |
| 2012-07-31 | $835.10K 10-Q · filed 2012-09-19 | |
| 2012-04-30 | $542.81K 10-K · filed 2013-06-26 | |
| 2012-01-31 | $650.35K 10-Q · filed 2012-03-15 | |
| 2011-10-31 | $781.51K 10-Q · filed 2011-12-15 | |
| 2011-07-31 | $1.06M 10-Q · filed 2011-09-19 | |
| 2011-04-30 | $889.38K 10-K · filed 2012-07-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |